Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Liabilities: 2020-2025

Historic Total Liabilities for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $201.6 million.

  • GeneDx Holdings' Total Liabilities fell 1.32% to $201.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.6 million, marking a year-over-year decrease of 1.32%. This contributed to the annual value of $174.1 million for FY2024, which is 8.71% down from last year.
  • Latest data reveals that GeneDx Holdings reported Total Liabilities of $201.6 million as of Q3 2025, which was up 7.99% from $186.7 million recorded in Q2 2025.
  • GeneDx Holdings' Total Liabilities' 5-year high stood at $407.6 million during Q2 2021, with a 5-year trough of $163.0 million in Q3 2023.
  • Over the past 3 years, GeneDx Holdings' median Total Liabilities value was $189.0 million (recorded in 2025), while the average stood at $189.9 million.
  • In the last 5 years, GeneDx Holdings' Total Liabilities soared by 1,266.33% in 2021 and then slumped by 53.72% in 2022.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Total Liabilities stood at $166.0 million in 2021, then surged by 42.92% to $237.2 million in 2022, then fell by 19.60% to $190.7 million in 2023, then decreased by 8.71% to $174.1 million in 2024, then declined by 1.32% to $201.6 million in 2025.
  • Its last three reported values are $201.6 million in Q3 2025, $186.7 million for Q2 2025, and $189.0 million during Q1 2025.